ZLD1039
ZLD1039 is a highly selective, orally active EZH2 inhibitor that potently inhibits wild-type and mutant PRC2 enzymatic activity. It demonstrates efficacy in suppressing breast tumor growth and metastasis in preclinical models, making it a valuable tool for oncology research targeting epigenetic mechanisms.
Product Specifications
CAS Number
1826865-46-6
Product Name Alternative
Histone Methyltransferase, HistoneMethyltransferase, EZH2, ZLD 1039, ZLD1039, ZLD-1039
Field of Research
Epigenetics & Chromatin
Purity
99.50% (May vary between batches)
Solubility
DMSO:9 mg/mL (14.69 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:0.5 mg/mL (0.82 mM)
Smiles
CCN (C1CCOCC1) c1cc (cc (C (=O) NCc2c3CCCCc3c (C) [nH]c2=O) c1C) -c1ccc (nc1) N1CCN (C) CC1
Molecular Formula
C36H48N6O3
Molecular Weight
612.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15299490 1 Vial
Lentiviral mouse Cckbr shRNA (UAS) - Lentiviral mouse Cckbr shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details ![EGF Receptor (L858R Mutant Specific) Antibody [B13L21]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
C18777-50uL 50 μL
EGF Receptor (L858R Mutant Specific) Antibody [B13L21]
Sign In for Pricing
View Details